Literature DB >> 22607671

Chromatin structure determines accessibility of a hairpin polyamide-chlorambucil conjugate at histone H4 genes in pancreatic cancer cells.

Christine Jespersen1, Elisabetta Soragni, C James Chou, Paramjit S Arora, Peter B Dervan, Joel M Gottesfeld.   

Abstract

We have shown that a specific pyrrole-imidazole polyamide-DNA alkylator (chlorambucil) conjugate, 1R-Chl, alters the growth characteristics of various cancer cell lines in culture, and causes these cells to arrest in the G2/M stage of the cell cycle, without apparent cytotoxicity. This molecule has also shown efficacy in several mouse xenograft models, preventing tumor growth. Previous microarray studies have suggested that members of the histone H4 gene family, H4c and H4j/k, are the primary targets of this molecule, leading to reduced histone mRNA synthesis and growth arrest in cancer cells. In the present study, we examine the effects of 1R-Chl on transcription of other members of the H4 gene family, with the result that mRNA transcription of most genomic copies of H4 are down-regulated by 1R-Chl in a human pancreatic cancer cell line (MIA PaCa-2), but not in a cell line of non-cancerous origin (HEK293 cells). The basis for this differential effect is likely an open chromatin conformation within the H4 genes in cancer cells. Chromatin immunoprecipitation experiments show increased histone acetylation on the histone H4 genes in cancer cells, compared to HEK293 cells, explaining the differential activity of this molecule in cancer versus non-cancer cells.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22607671      PMCID: PMC3362666          DOI: 10.1016/j.bmcl.2012.04.090

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  26 in total

1.  Dasatinib (BMS-354825), a dual SRC/ABL kinase inhibitor, inhibits the kinase activity of wild-type, juxtamembrane, and activation loop mutant KIT isoforms associated with human malignancies.

Authors:  Marcus M Schittenhelm; Sharon Shiraga; Arin Schroeder; Amie S Corbin; Diana Griffith; Francis Y Lee; Carsten Bokemeyer; Michael W N Deininger; Brian J Druker; Michael C Heinrich
Journal:  Cancer Res       Date:  2006-01-01       Impact factor: 12.701

Review 2.  Chemical approaches to the discovery and development of cancer therapies.

Authors:  Stephen Neidle; David E Thurston
Journal:  Nat Rev Cancer       Date:  2005-04       Impact factor: 60.716

3.  A two-hit mechanism for pre-mitotic arrest of cancer cell proliferation by a polyamide-alkylator conjugate.

Authors:  David Alvarez; C James Chou; Lucia Latella; Samantha G Zeitlin; Sherman Ku; Pier Lorenzo Puri; Peter B Dervan; Joel M Gottesfeld
Journal:  Cell Cycle       Date:  2006-07-17       Impact factor: 4.534

Review 4.  Targeting the EGFR pathway for cancer therapy.

Authors:  James B Johnston; Sri Navaratnam; Marshall W Pitz; Jerry M Maniate; Emilia Wiechec; Heinrich Baust; Joel Gingerich; Georgios P Skliris; Leigh C Murphy; Marek Los
Journal:  Curr Med Chem       Date:  2006       Impact factor: 4.530

Review 5.  Programmable DNA binding oligomers for control of transcription.

Authors:  Peter B Dervan; Raymond M Doss; Michael A Marques
Journal:  Curr Med Chem Anticancer Agents       Date:  2005-07

6.  Small molecules targeting histone H4 as potential therapeutics for chronic myelogenous leukemia.

Authors:  C James Chou; Michelle E Farkas; Sherry M Tsai; David Alvarez; Peter B Dervan; Joel M Gottesfeld
Journal:  Mol Cancer Ther       Date:  2008-04       Impact factor: 6.261

7.  Alpha-diaminobutyric acid-linked hairpin polyamides.

Authors:  Michelle E Farkas; Sherry M Tsai; Peter B Dervan
Journal:  Bioorg Med Chem       Date:  2007-08-22       Impact factor: 3.641

Review 8.  Targeted CML therapy: controlling drug resistance, seeking cure.

Authors:  Thomas O'Hare; Amie S Corbin; Brian J Druker
Journal:  Curr Opin Genet Dev       Date:  2005-12-15       Impact factor: 5.578

9.  Alkylation of template strand of coding region causes effective gene silencing.

Authors:  Ken-ichi Shinohara; Shunta Sasaki; Masafumi Minoshima; Toshikazu Bando; Hiroshi Sugiyama
Journal:  Nucleic Acids Res       Date:  2006-02-25       Impact factor: 16.971

10.  Unanticipated differences between alpha- and gamma-diaminobutyric acid-linked hairpin polyamide-alkylator conjugates.

Authors:  Sherry M Tsai; Michelle E Farkas; C James Chou; Joel M Gottesfeld; Peter B Dervan
Journal:  Nucleic Acids Res       Date:  2006-12-14       Impact factor: 16.971

View more
  9 in total

1.  Genome-wide Mapping of Drug-DNA Interactions in Cells with COSMIC (Crosslinking of Small Molecules to Isolate Chromatin).

Authors:  Graham S Erwin; Matthew P Grieshop; Devesh Bhimsaria; Asuka Eguchi; José A Rodríguez-Martínez; Aseem Z Ansari
Journal:  J Vis Exp       Date:  2016-01-20       Impact factor: 1.355

2.  Mapping polyamide-DNA interactions in human cells reveals a new design strategy for effective targeting of genomic sites.

Authors:  Graham S Erwin; Devesh Bhimsaria; Asuka Eguchi; Aseem Z Ansari
Journal:  Angew Chem Int Ed Engl       Date:  2014-07-27       Impact factor: 15.336

3.  Profiling of the Chromatin-associated Proteome Identifies HP1BP3 as a Novel Regulator of Cell Cycle Progression.

Authors:  Bamaprasad Dutta; Yan Ren; Piliang Hao; Kae Hwan Sim; Esther Cheow; Sunil Adav; James P Tam; Siu Kwan Sze
Journal:  Mol Cell Proteomics       Date:  2014-05-15       Impact factor: 5.911

4.  Synthetic genome readers target clustered binding sites across diverse chromatin states.

Authors:  Graham S Erwin; Matthew P Grieshop; Devesh Bhimsaria; Truman J Do; José A Rodríguez-Martínez; Charu Mehta; Kanika Khanna; Scott A Swanson; Ron Stewart; James A Thomson; Parameswaran Ramanathan; Aseem Z Ansari
Journal:  Proc Natl Acad Sci U S A       Date:  2016-11-08       Impact factor: 11.205

5.  Influence of Kv11.1 (hERG1) K+ channel expression on DNA damage induced by the genotoxic agent methyl methanesulfonate.

Authors:  Sara Fernández-Villabrille; Enol Álvarez-González; Francisco Barros; Pilar de la Peña; Luisa María Sierra
Journal:  Pflugers Arch       Date:  2021-01-15       Impact factor: 3.657

6.  Identification of Binding Targets of a Pyrrole-Imidazole Polyamide KR12 in the LS180 Colorectal Cancer Genome.

Authors:  Jason Lin; Kiriko Hiraoka; Takayoshi Watanabe; Tony Kuo; Yoshinao Shinozaki; Atsushi Takatori; Nobuko Koshikawa; Anandhakumar Chandran; Joe Otsuki; Hiroshi Sugiyama; Paul Horton; Hiroki Nagase
Journal:  PLoS One       Date:  2016-10-31       Impact factor: 3.240

7.  N-acetylcysteine-PLGA nano-conjugate: effects on cellular toxicity and uptake of gadopentate dimeglumine.

Authors:  Elham Poonaki; Mohammad Esfandyar; Hadi Hejazinia; Seyed Esmaeil Sadat Ebrahimi; Morteza Pirali Hamedani; Jafar Farzaneh; Mehdi Shafiee Ardestani
Journal:  IET Nanobiotechnol       Date:  2020-08       Impact factor: 1.847

8.  Deciphering the genomic targets of alkylating polyamide conjugates using high-throughput sequencing.

Authors:  Anandhakumar Chandran; Junetha Syed; Rhys D Taylor; Gengo Kashiwazaki; Shinsuke Sato; Kaori Hashiya; Toshikazu Bando; Hiroshi Sugiyama
Journal:  Nucleic Acids Res       Date:  2016-04-20       Impact factor: 16.971

Review 9.  The Road Not Taken with Pyrrole-Imidazole Polyamides: Off-Target Effects and Genomic Binding.

Authors:  Jason Lin; Hiroki Nagase
Journal:  Biomolecules       Date:  2020-04-03
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.